Flanax (Belmora LLC)


Welcome to the PulseAid listing for the Flanax drug offered from Belmora LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Belmora LLC
NON-PROPRIETARY NAME: Methyl Salicylate, Menthol, and Capsicum Oleoresin
SUBSTANCE NAME: METHYL SALICYLATE; MENTHOL; CAPSICUM OLEORESIN
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: LINIMENT
MARKETING CATEGORY NAME: OTC MONOGRAPH NOT FINAL
START MARKETING DATE: 2012-12-06
END MARKETING DATE: 2018-10-01


Flanax HUMAN OTC DRUG Details:

Item DescriptionFlanax from Belmora LLC
LABELER NAME: Belmora LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 13.8; 6; .014(g/60mL; g/60mL; g/60mL)
START MARKETING DATE: 2012-12-06
END MARKETING DATE: 2018-10-01
PRODUCT ID: 27854-100_45a544ae-2779-407a-833b-d8a52b38fe8c
PRODUCT NDC: 27854-100
APPLICATION NUMBER: part348

Other METHYL SALICYLATE; MENTHOL; CAPSICUM OLEORESIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Belmora LLCFlanax